Provided by Tiger Fintech (Singapore) Pte. Ltd.

Tempus AI

46.41
+0.81001.78%
Volume:8.09M
Turnover:374.39M
Market Cap:7.99B
PE:-7.45
High:49.60
Open:48.72
Low:44.16
Close:45.58
Loading ...

Stock Track | Tempus AI Stock Soars on Groundbreaking Cancer Sequencing Study

Stock Track
·
12 Nov 2024

BUZZ-Tempus AI drops after Stifel cuts to 'hold' from 'buy'

Reuters
·
11 Nov 2024

Tempus AI Shares Down 7% After Stifel Cuts to Hold From Buy

THOMSON REUTERS
·
11 Nov 2024

Stock Track | Tempus AI Stock Plunges on Analyst Downgrade

Stock Track
·
11 Nov 2024

Tempus Publishes Study Highlighting Benefits of Concurrent RNA and DNA Sequencing in Advanced Cancer Care

Business Wire
·
11 Nov 2024

Tempus AI Shares Down 5.2% Premarket After Stifel Cuts to Hold From Buy

THOMSON REUTERS
·
11 Nov 2024

Tempus AI Inc : Stifel Cuts to Hold From Buy; Raises Target Price to $65 From $45

THOMSON REUTERS
·
11 Nov 2024

Stifel Nicolaus Downgrades Tempus AI to Hold From Buy, Adjusts Price Target to $65 From $45

MT Newswires Live
·
11 Nov 2024

Tempus AI Cut to Hold From Buy by Stifel

Dow Jones
·
11 Nov 2024

Tempus AI downgraded to Hold from Buy at Stifel

TIPRANKS
·
11 Nov 2024

Stock Track | Tempus AI Plunges in Pre-Market on Analyst Downgrade

Stock Track
·
11 Nov 2024

Tempus AI, Inc.: Valuation Concerns and Growth Uncertainties Justify Hold Rating

TIPRANKS
·
11 Nov 2024

Stock Track | Tempus AI Stock Soars on Anticipated Conference Presentations

Stock Track
·
08 Nov 2024

Tempus Announces Nine Abstracts Accepted for Presentation at the 2024 Society for Immunotherapy of Cancer Annual Meeting

Business Wire
·
08 Nov 2024

Tempus AI reports Q3 results

seekingalpha
·
08 Nov 2024

BRIEF-Tempus Announces The Clinical Launch Of Its Immune Profile Score Algorithmic Test

Reuters
·
08 Nov 2024